Association between plasticity of adipose tissue and expression of adrenergic receptor and glucocorticoid receptor
Association between plasticity of adipose tissue and expression of adrenergic receptor and glucocorticoid receptor
批准号:
22700664
负责人:
TANIHATA Jun
金额:
$2.5万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011
中文摘要
本实验观察了克仑特罗(CLE)和地塞米松(DEX)(1 mg/kg体重/d,连续10天)对大鼠附睾周围(PED)、肾周围(PRE)和棕色脂肪组织中β_1-、β_2-和β_3-肾上腺素能受体(AR)、糖皮质激素受体(GR)和解偶联蛋白(UCP)-1,2,3 mRNA表达的影响。CLE显著降低PED和PRE脂肪组织相对于体重的相对重量,而不改变棕色脂肪组织的相对重量。另一方面,DEX增加PED和棕色脂肪组织的相对重量/体重,并减少PRE脂肪组织的相对重量/体重。上述结果提示,CLE和DEX对β-AR、GR和UCPs mRNA表达及脂肪组织质量的影响与脂肪组织类型有关。
英文摘要
We studied the effects of clenbuterol(CLE) and dexamethasone(DEX)(each dose=1mg/kg body weight per day for 10 days) on the mRNA expressions ofβ_1-,β_2-andβ_3-adrenergic receptor(AR), glucocorticoid receptor and uncoupling protein(UCP)-1, 2 and 3 in periepididymal(PED), perirenal(PRE) and brown adipose tissues. CLE significantly decreased the relative weight of PED and PRE adipose tissues per body weight without changing that of brown adipose tissue. On the other hand, DEX increased the relative weight of PED and brown adipose tissues per body weight, and decreased that of PRE adipose tissue per body weight. These results suggest that the effects of CLE and DEX on the mRNA expressions ofβ-ARs, GR, and UCPs and adipose tissue mass depend on the type of adipose tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
患者由来細胞を用いたデュシェンヌ型筋ジストロフィーに対するエクソン・スキッピング治療の開発
使用患者来源的细胞开发外显子跳跃疗法治疗杜氏肌营养不良症
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[斉藤崇, 永田哲也, 青木吉嗣, 谷端淳, 増田智, 本橋裕子, 横田俊文, 武田伸一]
通讯作者:
武田伸一
Functional role of truncated dystrophin with deletion exon 45-55
-
批准号:25860306
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2013
-
负责人:TANIHATA Jun
-
依托单位:
海外基金